ClinicalTrials.gov
ClinicalTrials.gov Menu

The Efficacy, Safety, and Tolerability of Laquinimod in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) (CONCERTO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01707992
Recruitment Status : Completed
First Posted : October 16, 2012
Last Update Posted : May 17, 2017
Sponsor:
Information provided by (Responsible Party):
Teva Pharmaceutical Industries

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 9, 2017
  Actual Study Completion Date : April 19, 2017